301 BINNEY STREET, CAMBRIDGE, MA
Other Events
Merger Agreement Announcement Conference Call, Investor Presentation
Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Investor Presentation
News
Material Contracts
Q1
Amended Annual Report
Q3
Q2
FY 2024
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload